Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX1SE2
|
||||
| Drug Name |
5-(3-Morpholin-4-yl-propoxy)-1-phenyl-1H-benzoimidazole
|
||||
| Synonyms |
CHEMBL80915
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C20H23N3O2
|
||||
| Canonical SMILES |
C(COc1ccc2c(c1)ncn2c3ccccc3)CN4CCOCC4
|
||||
| InChI |
InChI=1S/C20H23N3O2/c1-2-5-17(6-3-1)23-16-21-19-15-18(7-8-20(19)23)25-12-4-9-22-10-13-24-14-11-22/h1-3,5-8,15-16H,4,9-14H2
|
||||
| InChIKey |
QPLWWFCARNPZGZ-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Basic fibroblast growth factor receptor 1 | Target Info | [1587926] | ||
| Platelet-derived growth factor receptor | Target Info | [1587926] | |||
| KEGG Pathway | MAPK signaling pathway | ||||
| Ras signaling pathway | |||||
| Rap1 signaling pathway | |||||
| PI3K-Akt signaling pathway | |||||
| Adherens junction | |||||
| Signaling pathways regulating pluripotency of stem cells | |||||
| Regulation of actin cytoskeleton | |||||
| Pathways in cancer | |||||
| Proteoglycans in cancer | |||||
| Prostate cancer | |||||
| Melanoma | |||||
| Central carbon metabolism in cancer | |||||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Angiogenesis | ||||
| FGF signaling pathway | |||||
| Pathway Interaction Database | Glypican 1 network | ||||
| Syndecan-4-mediated signaling events | |||||
| N-cadherin signaling events | |||||
| FGF signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.